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INTRODUCTION
Salt tablets and water (8 grams salt in 0.97 liters of water) is the current fluid-loading counter-
measure used by Shuttle crewmembers to acutely restore plasma volume during the 1 to 2 hours
before touchdown [2]. Presumably, increasing plasma volume will enhance cardiac filling and
improve postflight orthostatic intolerance. Based on our experiences with ground-based studies,
anecdotal reports from Shuttle crewmembers, and the Russian literature [9, 12], we know that
some individuals experience unpleasant side effects including nausea, stomach cramping, diar-
rhea, and vomiting after taking this quantity of salt tablets and water. Our goal is to screen a
variety of drinking solutions for their effectiveness in expanding plasma volume while inducing
minimal side effects over a time profile similar to a Shuttle landing. In this report we compared
responses to Astro-ade, a fluid-loading solution developed at the NASA Ames Research Center,
with the current Shuttle fluid-loading countermeasure.
Based on previous studies [7, 8, 9, 10] it appears that isotonic (0.9%) or slightly hypertonic
(1.07%) salt solutions are most effective in acutely expanding plasma volume for prolonged
periods. The critical factor seems to be the isotonicity rather than composition; as an isotonic
salt/sugar solution such as 0.74% saline and 1% glucose [7] or an isotonic bouillon drink [11]
have very different compositions yet both successfully expand plasma volume for several hours.
Hypertonic salt or salt/sugar solutions stimulate a brisk diuresis and are less effective in expand-
ing plasma volume [8]. Similarly, hypotonic solutions (water, 0.45% saline, or 1% glucose)
resulted in only small transient increases in plasma volume when given to hypovolemic [8] or
normally hydrated [7] subjects.
Our specific aim was to compare the responses of a recently developed isotonic electrolyte solu-
tion, Astro-ade [8], to the current fluid-loading countermeasure (salt tablets with water), to
determine if Astro-ade is equally effective in expanding plasma volume in normally hydrated
individuals while inducing fewer side effects. The chemical characteristics of Astro-ade are
shown in Table 1.
Table 1. Astro-Ade chemical composition [8]
Contents
Sodium Chloride (gm) 9.00
Sodium Citrate (gm) 15.44
Aspartame (gm) 0.72
Total Volume (mL) 2000
Osmolality 270
Ionic Concentrations
(mEq[%wt/vol])
Na + 157 (0.360)
K + 0
CI- 76 (0.270)
Mg ++ 0
Ca ++ 0
P+++ .__.Q
Total 233 (0.630)
* Shaklee U.S., Inc. San Francisco, CA 94111
METHODS
Subjects
Eleven healthy men (Table 2) volunteered for this study and participated in one to three trials.
The three trial conditions were: no fluid loading (control), orange-flavored Astro-ade ingestion
(Astro-ade), and intake of salt tablets with water (tablets).
Table 2. Subject characteristics
Subject Age (yr) Height (cm) Weight (kg)
Astro-ade Trials
1 30 167 64.5
2 29 182.5 78.2
3 36 191 99
4 32 175 100.2
5 31 182 92
6 34 188 74.5
Salt Tablet Trials
1 30 167 64.5
2 29 182.5 78.2
3 36 191 99
5 31 182 92
7 28 170.2 73.2
8 42 175.5 84.5
Control Trials
1 3O 167 65.5
2 29 182.5 78.2
8 42 175.5 84.5
9 45 167 75.7
i0 38 166.5 78
11 32 175 86
Overall Protocol
Each subject had a light, nonsalty breakfast and reported to the laboratory at approximately
7:30am. They were immediately given 5 mL/kg of water to drink so that they would be well -
hydrated at the beginning of the test day. A catheter was inserted in an arm vein, and each sub-
ject rested quietly in a recliner chair for the remaining 4.5 hours of the study, except to urinate as
needed. The subjects sat with the chairs fully reclined so that their feet were approximately at
heart level. Immediately after each blood draw, subjects were given the opportunity to empty
their bladder. In this way, subjects maintained the same reclining position for at least 30 minutes
immediately prior to each blood draw.
Bodyweightswereobtainedfor eachsubjectimmediatelybeforebeginningfluid loadingand4.5
hourslater. Fluid balancewascalculatedby measuringthedifferencebetweenurine outputand
fluid intakebetweenthe startof fluid loadingand4.5 hourslater. Heart ratesandbloodpres-
sureswereobtainedimmediatelybeforeeachbloodsampling.
In all trials,afterinitial 30minutesof quietrest,thebaselinebloodsamplewasobtained.During
fluid-loading trials,eachsubjecteitherslowly sippedthe Astro-adesolution (15mL/kg) or took
salttabletsandwaterduring thenext60minutes(hydrationperiod). The salt tabletmixturewas
adjustedsothat thequantityof saltandwatertakenwas in aratio of approximately1 salt tablet
(1gm) for each 110mL of water. Thetotalvolumetakenwasadjustedto thenearestwholesalt
tablet. For example,a 70-kg man would havea target fluid requirementof 70x15mL/kg =
1050mL. For this volumeof fluid, 9.54salt tabletswould berequired(1050mL/110 mL- g-I =
9.54g, or 9.54tablets).This subjectwould beadministered10salt tabletsand 1100mL of fluid.
Postfluid-loadingblood sampleswere obtainedat l hour, 1.5,2.5, 3.5, and 4.5 hoursafter the
startof thehydrationperiod. In anQminalShuttlelanding,fluid ingestionwould beginapproxi-
mately2 hoursprior to touchdown. In theeventof a one-revolutionwave-off, therewould bea
90-minutedelaybeforetouchdown(or 3.5hoursafterbeginningfluid loading).
Subjectswere given a questionnaireto completedescribingthe presenceof certainsymptoms
threetimesduring the study: during thebaselineperiod,at the endof thehydrationperiod,and
just beforereleaseat theendof thestudy. Subjectswereaskedto circle "yes" or "no" whether
theywereexperiencingsymptomsof headache,nausea,vomiting, stomachcramping,diarrhea,or
thirst.
Control subjectsfollowed an identical protocol exceptthey did not drink during the hydration
period. During all threetrials,no further fluid or food ingestionwasallowedduringor after the
hydrationperiod.
Measurements
From each blood sample, duplicate measurements were made of hematocrit and hemoglobin
concentration (Coulter Counter), serum osmolality (freezing-point depression), serum sodium
concentration (ion analyzer), and blood glucose using a modified enzymatic approach (Beckman
Synchron CX5 System).
Data Analysis
Changes in plasma volume between the baseline sample and each succeeding blood sample were
calculated from hematocrit and hemoglobin values using the formula described by Dill and
Costill [4]. All dependent blood variables were compared for differences across time with a
repeated measures ANOVA design, and among groups using a nonrepeated measures design
(Clear Lake ANOVA Statistical Program). When a significant effect was found among groups
or times, post hoc multiple comparisons were performed with a Duncan Multiple Range Test.
Changes in body weight and fluid balance for the three groups were compared by using a non-
paired t test. For all comparisons, statistical significance was determined when p<0.05 and data
are presented as the mean + standard error.
RESULTS
Hematocrits
The hematocrit responses did not differ significantly (p<0.59) among the three groups. How-
ever, there were significant differences across time (p<0.002) and a significant interaction
between time and group. For the Astro-ade and salt tablet groups, hematocrit had decreased
slightly from baseline approximately 2.5 hours after drinking and returned to baseline during the
remainder of the trial. In contrast, hematocrit continuously increased across time in the control
group.
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Figure 1. Hematocrit values at baseline and at intervals (hours) after beginning of fluid
loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=0.59; time effect,
p=O.O1; interaction, p=O.O1).
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Hemoglobin Concentration
There were no significant group differences, although hemoglobin concentration tended to
decline after drinking in the fluid-loading groups while it continuously increased in the control
group. The time effect and the group/time interaction were significant (p<0.0001).
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Figure 2. Hemogobin concentration at baseline and at intervals (hours) after beginning of
fluid loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=0.65; time
effect, p-O.O1; interaction, p=O.O1).
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Plasma Osmolality
The plasma osmolality responses did not differ (p=0.21) among groups or across time (p= 0.34).
There was a borderline interaction effect, p<0.05.
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Figure 3. Plasma osmolality at baseline and at intervals (hours) after beginning of fluid
loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=0.21; time effect,
p=0.34; interaction, p=O.05).
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Serum sodium concentration also did not differ among groups (p=0.67) or across time (p=0.83).
The interaction effect was not significant (p<0.37).
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Figure 4. Plasma sodium concentration at baseline and at intervals (hours) after beginning of
fluid loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=0.67; time
effect, p = 0.83; interaction, p = 0.3 7).
Blood Glucose
Blood glucose concentration decreased significantly as a function of time (p<0.0001), becoming
significantly lower than baseline within one hour. A similar response occurred in all three
groups.
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Figure 5. Blood glucose concentration at baseline and at intervals (hours) after beginning of
fluid loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=0.29; time
effect, p = 0.01, interaction, p = 0.64).
Percent Change in Plasma Volume after Drinkin_
The plasma volume responses were similar after drinking each of the fluid-loading solutions.
Plasma volume decreased significantly during the first hour after drinking. Then, plasma volume
increased above baseline with a peak at approximately 2.5 hours after the start of fluid ingestion.
Thereafter, it decreased to baseline levels during the last two hours of the study. During the
control studies, plasma volume decreased progressively during the course of the study. This
control response differed significantly (p<0.01) from the drink responses.
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Figure 6. Percent change in plasma volume between baseline and at intervals (hours) after
fluid loading. Results shown are the mean +_SE, n=6 in each group (group effect, p=O.Ol ; time
effect, p = 0.01; interaction, p = 0.01).
Individual and mean blood results are presented in Appendix B.
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Both the salt tablet/water and Astro-ade drinks caused gastrointestinal distress in some subjects.
Symptoms of stomach cramps, diarrhea, and indigestion were reported after both drinks. Nausea
or vomiting were each seen in one subject after ingestion of salt tablets and water. The only
symptom measured that appeared in the control group was thirst.
Table 3. Symptoms (numbers correspond to subject identification in Table 2)
Symptom Baseline 1 Hour 4.5 Hours
Astro-ade Trials
Headache
Nausea
Vomiting
Thirst
Cramping
Diarrhea
Indigestion
Headache
Nausea
Vomiting
Thirst
Cramping
Diarrhea
Indigestion
Headache
Nausea
Vomiting
Thirst
Cramping
Diarrhea
Indigestion
6 6
2 2,3,4
Salt Tablet Trials
Control Trials
5
5
2
2,3
2
2,11 2,8 8,11
Heart Rates and Blood Pressures (Appendix C)
There were no significant differences among groups for heart rate, systolic or diastolic blood
pressure. Blood pressures did not change significantly across time in this study, however, heart
rates did change significantly (p<0.0001) across time. From a simple effect analysis, heart rate
decreased significantly between baseline and all other sampling times in the salt tablet and in the
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controlgroup. Heart ratehaddecreasedanaverageof 8 beatsperminutebetweenbaselineand
theendof fluid loadingfor eachof thesegroups.For theAstro-adegroup,theaverageheartrate
decreasedby 2beatsperminuteduringthis interval.
Flokt Balarlc¢ and Body Weights (Appendix C)
There was no significant group effect for the change in body weight during the study (p<0.12).
Between baseline and the end of the study, the Astro-ade group lost 0.25 _+0.25 kg, the salt tablet
group lost 0.34 _+0.12 kg, and the control group lost 1.00 _+0.36 kg.
Fluid balance (urine output--fluid intake) differed significantly among groups, p< 0.01. The
control group ended the study in a negative fluid balance (-867 +300 mL), the Astro-ade group
was in positive fluid balance (291 +155 mL), and the salt tablet group maintained fluid balance
(0.8 mL +182 mL). (These differences are not corrected for insensible water loss which would
be expected to average approximately 100 mL/hour or a total of about 450 mL.) Thus, all three
groups lost some weight during the study.
DISCUSSION
Fluid-Loading Hydrated Subjects
Both Astro-ade and salt tablets and water significantly expanded plasma volume between 2 to 3
hours after ingestion, the time of a nominal Shuttle landing. Although the plasma volume ex-
pansion compared to baseline averaged only 2%, the control group had a 6.0% decrease in
plasma volume, probably due to the prolonged hypokinesia and lack of fluid intake. Thus, both
drink solutions increased plasma volume compared to control by an amount which should
improve cardiac filling during an orthostatic stress.
The expansion of plasma volume seen in these subjects (2%) is somewhat smaller than that pre-
viously noted by Frey and coworkers [7] (5%) in five hydrated men after ingestion of a similar
volume of 0.9% saline solution. However, such a small difference would be within the experi-
mental error of our measurement procedures.
Fluid-Loading Hypohydrated Subjects
The effectiveness of a hydration solution may be influenced by the hydration status of the sub-
ject, where hypovolemic subjects retain more of a fluid load and have a greater expansion in
plasma volume. As an example, the increase in plasma volume after drinking in these initially
hydrated subjects is considerably smaller than the increases we found previously in subjects who
had been given a short-acting diuretic (Lasix ®) 2 hours prior to fluid loading (Figure 7). In our
earlier study, both an isotonic saline solution and the salt tablet and water treatment increased
plasma volume an average of 10% at 2 hours after beginning fluid ingestion. Similarly, Green-
leaf and coworkers [8] reported a relatively large increase in plasma volume (8%) 70 minutes
after seven hypovolemic subjects drank 12 mL/kg of Astro-ade. In Greenleaf's study, the sub-
jects had been made hypovolemic by restricting fluid intake and eating dry food for 24 hours
prior to testing.
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Figure 7. Percent changes in plasma volume compared to baseline from a previous study
comparing euhydrated subjects (n=6), subjects dehydrated with Lasix ®, then rehydrated with an
isotonic saline solution (n=6), and subjects dehydrated with Lasix ®, then rehydrated with salt
tablets with water (n=6). Sample 1 - baseline; sample 2 - 30 minutes after Lasix ® administra-
tion; sample 3 - 1 hour after Lasix ® administration; sample 4 - 2 hours after Lasix ®
administration, prerehydration; sample 5 - 1 hour after rehydration; sample 6 - 2 hours after
rehydration; sample 7 - 3 hours after rehydration; and sample 8 - 4 hours after rehydration.
Fluid Loading During a Shuttle Mission
When Shuttle crewmembers begin fluid loading, we suspect that in most cases, they are in a
normally hydrated state with respect to their microgravity environment. After several days of
spaceflight, crewmembers should have attained some degree of adaptation to microgravity and
therefore fluid loading would represent an overhydration, stimulating the hormonal and renal
responses to excrete the excess volume and salt. Some crewmembers, however, may be hypohy-
drated at the end of a mission due to over-exertion, decreased fluid intake due to multiple factors,
e.g., less palatable water or food, or incomplete recovery from an earlier bout of space adaptation
syndrome. Those crewmembers would have the most to gain from a fluid-loading counter-
measure.
Another consideration is that, during a nominal Shuttle mission, during the two hours after fluid
loading crewmembers are re-exposed to gravity: approximately 1.1 to 1.6 g during reentry
(Appendix A) and one g after landing. In response to the hydrostatic forces, body fluids will
redistribute to the lower body, promoting the hormonal and neural responses that act to retain
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bodyfluids. We expectthat a fluid-loading solutionwhich proveseffective in a hydratedindi-
vidualmaybeevenmoreeffectiveduringa Shuttlelanding.
Fluid Loading and Orthostatic Tolerance after Short Exposures to Microgravity
The major purpose of the fluid-loading countermeasure is to improve orthostatic tolerance during
and after landing. There are an abundance of studies [8, 9, 10, 11, 12] which have shown that
acutely expanding plasma volume with an isotonic fluid after a short-term bed rest or space flight
may improve orthostatic responses and that the mechanism is most likely due to expansion of
plasma volume. Grigoriev [9] concluded that the effect from the salt tablet and water counter-
measure is most likely due to a beneficial effect to increase circulating blood volume. On the
other hand, Kakurin [12] commented that the beneficial effects seen during an LBNP challenge 8
to 10 hours after intake of fluid and salt could also be related to an effect of sodium chloride on
vascular tone. Changes in extracellular sodium concentration have been shown to increase the
sensitivities of both arterial and cardiopulmonary baroreceptor responses [ 1]. However, pro-
longed exposures to elevated levels of plasma sodium result in depressed carotid baroreflex
function [3]. It is unlikely that a sodium or osmotic effect would have a major influence on
orthostatic responses after drinking isotonic solutions similar to those tested in this study since
they did not significantly alter plasma osmolality or sodium concentration.
Fluid Loading and Orthostatic Responses after Longer Space Flights
We have hypothesized that, after longer space flights, a fluid-loading countermeasure will
become less effective [5]. This generalization is based on our findings from a 13-day bed rest
study in which an LBNP/fluid-loading countermeasure restored plasma volume during bed rest,
but did not improve LBNP responses [6]. Vernikos et al. reviewed similar observations of lack
of correlation between changes in plasma volume and orthostatic responses during several bed
rest studies [13]. Therefore, it is important to note that the present fluid-loading solutions are
designed to restore plasma volume, which is only one of the mechanisms for postflight ortho-
static intolerance. As flight duration increases, additional countermeasures will be required to
restore baroreflex function, decrease venous compliance, maintain skeletal muscle mass and
tone, etc.
CONCLUSIONS
. Both salt tablets with water and Astro-ade improved maintenance of plasma volume
approximately 2 to 3 hours after fluid ingestion, in contrast to the control group whose
plasma volume declined by 6% during this same time interval. Both drinks appeared
equally effective in maintaining plasma volume.
. Side effects were reported in approximately one out of six subjects after both drinks. These
results agree with our ground-based experiences and with Russian reports [9, 12] that a
single salt tablet and water dose "turned out to be unpromising, since it elicited a number of
unpleasant subjective sensations and dyspeptic phenomena."
.
For crewmembers who have an aversion toward or severe side effects from salt tablets with
water, Astro-ade may offer an alternate countermeasure to restore plasma volume.
However, this solution also provoked unpleasant sensations and further work is needed to
identify more palatable drinks with fewer side effects. Alternative solutions may include
13
.bouillon, isotonic salt/sugar solutions, salty foods and fluid supplements, multiple salt/fluid
doses, and pharmacological aids such as Florinef or inhaled Antidiuretic Hormone.
Once a promising fluid-loading solution is identified (one that not only improves plasma
volume but also has no side effects), further studies will be required to verify its effective-
ness in improving orthostatic responses after varying periods of simulated weightlessness.
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maintained PV at 2-3 hours after ingestion compared to the Control Group, which had a 6% decline. Side effects (thirst,
stomach cramping, and diarrhea) were noted in at least one subject in both the Astro-ade and Salt Tablet Groups. Nausea and
vomiting were reported in one subject in the Salt Tablet Group. We conclude that Astro-ade may be offered as an alternate
fluid-loading countermeasure but further work is needed to develop a solution that is more palatable and has fewer side effects.
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